Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs
Launched by OTTAWA HEART INSTITUTE RESEARCH CORPORATION · Nov 1, 2013
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient has been referred to DEP for T2DM diabetes or pre-diabetes.
- • The patient is a current smoker (self-report of daily smoking a minimum of 1 cigarette per day in the 30 days preceding recruitment).
- • The patient is aged between 18 years and 80 years.
- Exclusion Criteria:
- • The patient is currently involved in any other smoking cessation intervention.
- • The patient is able to read and understand French or English.
- • The patient is able to and willing to provide informed consent.
About Ottawa Heart Institute Research Corporation
The Ottawa Heart Institute Research Corporation is a leading clinical research organization dedicated to advancing cardiovascular medicine through innovative research and clinical trials. Affiliated with the renowned University of Ottawa Heart Institute, the corporation focuses on conducting high-quality, ethically-driven studies that aim to improve patient outcomes and enhance understanding of heart-related diseases. With a commitment to collaboration and excellence, the organization engages multidisciplinary teams of researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective therapies and interventions for cardiovascular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Patients applied
Trial Officials
Robert Reid, PhD., MBA
Principal Investigator
Ottawa Heart Institute Research Corporation
Andrew Pipe, MD, FRCPC
Study Chair
Ottawa Heart Institute Research Corporation
Oh Paul, MD, FRCPC
Study Chair
Toronto Rehabilitation Institute
Anil Gupta, MD, FRCPC
Study Chair
Trillium Heath Centre
Kocourek Jana, MA
Study Chair
Ottawa Heart Institute Research Corporation
Mullen Kerri-Anne, MSc.
Study Chair
Ottawa Heart Institute Research Corporation
Aiken Debbie, BScN
Study Chair
Ottawa Heart Institute Research Corporation
Tulloch Heather, Ph.D., Psych.
Study Chair
Ottawa Heart Institute Research Corporation
David Arbeau, BA, BTech, RT
Study Chair
Horizon Health Network
Malcolm Janine, MD, FRCPC
Study Chair
Faculty of Medicine, University of Ottawa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials